We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.76B
1-Year Est. Return 223.33%
This Fund
S&P 500
This Quarter Est. Return
+19.84%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$2.88B
AUM Growth
+$360M
Cap. Flow
+$23.1M
Cap. Flow %
0.8%
Top 10 Hldgs %
84.68%
Holding
41
New
2
Increased
5
Reduced
3
Closed
3

Top Buys

Rank Stock Value
1
OBSV
ObsEva SA Ordinary Shares
OBSV
+$41M
2
CASC
Cascadian Therapeutics, Inc.
CASC
+$30.6M
3
ADAP
Adaptimmune Therapeutics
ADAP
+$9.38M
4
AFMD
Affimed
AFMD
+$8.55M
5
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
+$4.33M

Top Sells

Rank Stock Value
1
CLVS
Clovis Oncology, Inc.
CLVS
+$50.6M
2
GRPN icon
Groupon
GRPN
+$19.3M
3
HIVE
Aerohive Networks
HIVE
+$1.83M
4
ZSAN
Zosano Pharma Corporation
ZSAN
+$1.6M
5
AGRX
Agile Therapeutics
AGRX
+$761K

Sector Composition

Rank Sector Weight
1 Healthcare 86.21%
2 Communication Services 2.06%
3 Consumer Discretionary 1.42%
4 Technology 0.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AFMD
26
DELISTED
Affimed
AFMD
$8.94M 0.31%
+388,889
New +$8.55M
SYBX
27
DELISTED
Synlogic
SYBX
$6.51M 0.23%
28,332
– –
DZSI
28
DELISTED
DZS Inc. Common Stock
DZSI
$5.97M 0.21%
956,255
-3
-0% -$16
VIRX
29
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$5.32M 0.19%
37,094
– –
AKTX
30
Akari Therapeutics
AKTX
$14M
$5M 0.17%
565
– –
CSBR icon
31
Champions Oncology
CSBR
$73.1M
$4.95M 0.17%
1,562,500
– –
ORKA
32
Oruka Therapeutics
ORKA
$5.9B
$3.72M 0.13%
6,760
– –
ROKA
33
DELISTED
Sorrento Tech, Inc. Common Stock
ROKA
$3.18M 0.11%
893,471
– –
ARQL
34
DELISTED
Arqule Inc
ARQL
$2.67M 0.09%
2,520,316
– –
OREX
35
DELISTED
Orexigen Therapeutics, Inc.
OREX
$1.28M 0.04%
370,900
– –
PRTK
36
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1.27M 0.04%
66,245
– –
GYRE icon
37
Gyre Therapeutics
GYRE
$648M
$410K 0.01%
5,799
– –
AVTX icon
38
Avalo Therapeutics
AVTX
$1.03B
$402K 0.01%
207
– –
AGRX
39
DELISTED
Agile Therapeutics
AGRX
– –
-67
Closed -$761K
CLVS
40
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-1,139,890
Closed -$50.6M
ZSAN
41
DELISTED
Zosano Pharma Corporation
ZSAN
– –
-2,933
Closed -$1.6M
1
2

Similar funds

NM
NWI Management New York $1.76B AUM 45.08% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.76B AUM 13.06% 1-Year Est. Return
SW
Simplicity Wealth Summit, New Jersey $1.76B AUM 20.49% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
PWP
Principle Wealth Partners Madison, Connecticut $1.75B AUM 21.63% 1-Year Est. Return
CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
KOCAA
Knights of Columbus Asset Advisors New Haven, Connecticut $1.77B AUM 31.28% 1-Year Est. Return

NEA Management Company's Q1 2017 Portfolio in Review

As of Q1 2017, NEA Management Company held 41 positions worth $2.88B, up 14% from $2.51B the previous quarter. Its ten largest holdings account for 85% of the portfolio.

NEA Management Company's Q1 2017 filing shows 2 new, 5 increased, 3 reduced and 3 closed positions. Its largest new stake was ObsEva SA Ordinary Shares: 3,336,563 shares worth $34.7M. The largest sale was Clovis Oncology, Inc., an estimated $50.6M.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, down from 87% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • NEA Management Company's largest Q1 2017 buy was ObsEva SA Ordinary Shares: 3,336,563 shares worth $34.7M.
  • NEA Management Company added most to Cascadian Therapeutics, Inc. in Q1 2017, an estimated $30.6M increase.
  • NEA Management Company's biggest Q1 2017 reduction was Groupon, cutting an estimated $19.3M.
  • NEA Management Company fully exited Clovis Oncology, Inc. in Q1 2017, selling an estimated $50.6M.
  • NEA Management Company's ten largest holdings make up 85% of its $2.88B portfolio in Q1 2017.
  • NEA Management Company opened 2 new positions and closed 3 in Q1 2017.
  • NEA Management Company's portfolio value rose 14% quarter-over-quarter to $2.88B.

Based on NEA Management Company's 13F filing for Q1 2017, filed 10 May 2017.